254TiP ENGOT-cx11/KEYNOTE-A18: A phase III, randomized, double-blind study of pembrolizumab with chemoradiotherapy in patients with high-risk locally advanced cervical cancer.
Saved in:
| Title: | 254TiP ENGOT-cx11/KEYNOTE-A18: A phase III, randomized, double-blind study of pembrolizumab with chemoradiotherapy in patients with high-risk locally advanced cervical cancer. |
|---|---|
| Authors: | Lorusso, D.1, Xiang, Y.2, Colombo, N.3, Coleman, R.4, Randall, L.5, Duska, L.6, Hasegawa, K.7, Nogueira-Rodrigues, A.8, Cibula, D.9, Mirza, M.R.10, You, B.11, Oaknin, A.12, Christiaens, M.13, Taskiran, C.14, Sehouli, J.15, Korach, J.16, Marth, C.17, Keefe, S.18, Puglisi, M.18, Pignata, S.19 |
| Source: | Annals of Oncology. 2020 Supplement 6, Vol. 31, pS1341-S1342. 2p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 152684761 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 254TiP ENGOT-cx11/KEYNOTE-A18: A phase III, randomized, double-blind study of pembrolizumab with chemoradiotherapy in patients with high-risk locally advanced cervical cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Lorusso%2C+D%2E%22">Lorusso, D.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Xiang%2C+Y%2E%22">Xiang, Y.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Colombo%2C+N%2E%22">Colombo, N.</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Coleman%2C+R%2E%22">Coleman, R.</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Randall%2C+L%2E%22">Randall, L.</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Duska%2C+L%2E%22">Duska, L.</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Hasegawa%2C+K%2E%22">Hasegawa, K.</searchLink><relatesTo>7</relatesTo><br /><searchLink fieldCode="AR" term="%22Nogueira-Rodrigues%2C+A%2E%22">Nogueira-Rodrigues, A.</searchLink><relatesTo>8</relatesTo><br /><searchLink fieldCode="AR" term="%22Cibula%2C+D%2E%22">Cibula, D.</searchLink><relatesTo>9</relatesTo><br /><searchLink fieldCode="AR" term="%22Mirza%2C+M%2ER%2E%22">Mirza, M.R.</searchLink><relatesTo>10</relatesTo><br /><searchLink fieldCode="AR" term="%22You%2C+B%2E%22">You, B.</searchLink><relatesTo>11</relatesTo><br /><searchLink fieldCode="AR" term="%22Oaknin%2C+A%2E%22">Oaknin, A.</searchLink><relatesTo>12</relatesTo><br /><searchLink fieldCode="AR" term="%22Christiaens%2C+M%2E%22">Christiaens, M.</searchLink><relatesTo>13</relatesTo><br /><searchLink fieldCode="AR" term="%22Taskiran%2C+C%2E%22">Taskiran, C.</searchLink><relatesTo>14</relatesTo><br /><searchLink fieldCode="AR" term="%22Sehouli%2C+J%2E%22">Sehouli, J.</searchLink><relatesTo>15</relatesTo><br /><searchLink fieldCode="AR" term="%22Korach%2C+J%2E%22">Korach, J.</searchLink><relatesTo>16</relatesTo><br /><searchLink fieldCode="AR" term="%22Marth%2C+C%2E%22">Marth, C.</searchLink><relatesTo>17</relatesTo><br /><searchLink fieldCode="AR" term="%22Keefe%2C+S%2E%22">Keefe, S.</searchLink><relatesTo>18</relatesTo><br /><searchLink fieldCode="AR" term="%22Puglisi%2C+M%2E%22">Puglisi, M.</searchLink><relatesTo>18</relatesTo><br /><searchLink fieldCode="AR" term="%22Pignata%2C+S%2E%22">Pignata, S.</searchLink><relatesTo>19</relatesTo> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2020 Supplement 6, Vol. 31, pS1341-S1342. 2p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=152684761 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2020.10.248 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 2 StartPage: S1341 Titles: – TitleFull: 254TiP ENGOT-cx11/KEYNOTE-A18: A phase III, randomized, double-blind study of pembrolizumab with chemoradiotherapy in patients with high-risk locally advanced cervical cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lorusso, D. – PersonEntity: Name: NameFull: Xiang, Y. – PersonEntity: Name: NameFull: Colombo, N. – PersonEntity: Name: NameFull: Coleman, R. – PersonEntity: Name: NameFull: Randall, L. – PersonEntity: Name: NameFull: Duska, L. – PersonEntity: Name: NameFull: Hasegawa, K. – PersonEntity: Name: NameFull: Nogueira-Rodrigues, A. – PersonEntity: Name: NameFull: Cibula, D. – PersonEntity: Name: NameFull: Mirza, M.R. – PersonEntity: Name: NameFull: You, B. – PersonEntity: Name: NameFull: Oaknin, A. – PersonEntity: Name: NameFull: Christiaens, M. – PersonEntity: Name: NameFull: Taskiran, C. – PersonEntity: Name: NameFull: Sehouli, J. – PersonEntity: Name: NameFull: Korach, J. – PersonEntity: Name: NameFull: Marth, C. – PersonEntity: Name: NameFull: Keefe, S. – PersonEntity: Name: NameFull: Puglisi, M. – PersonEntity: Name: NameFull: Pignata, S. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 11 Text: 2020 Supplement 6 Type: published Y: 2020 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 31 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
